Perioperative medicine & outcomes
Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study
Main finding · NMBA-related anaphylaxis and pholcodine consumptionResult — go to the resultOdds ratio 4.2 95% CI 2.3–7.0Authors' conclusion
Patients exposed to pholcodine 12 months before NMBA exposure have a significantly higher risk of an NMBA-related anaphylaxis. The low positive predictive values of pholcodine and quaternary ammonium sIgEs precludes their use to identify a population with a high risk of NMBA-related anaphylaxis.
Study context
- Population
- Patients undergoing anaesthesia with neuromuscular blocking agents (NMBAs) in France
- Participants
- 167 vs 334
- Comparison
- Cases vs Controls
- Casesn = 167
- Controlsn = 334reference
- Outcome
- Association between pholcodine exposure (self-administered questionnaire and pharmacy records) and NMBA-related anaphylaxis
- Follow-up
- Within a year before anaesthesia
Methodological detailsmulticentre, matched (two controls per case by age, sex, type of NMBA, geographic area, season)
- Multicentre
- Matched (two controls per case by age, sex, type of NMBA, geographic area, season)
Main finding
As reported in the abstract
NMBA-related anaphylaxis and pholcodine consumption
Odds ratio
4.2
95% CI 2.3–7.0
Pholcodine exposure within a year before anaesthesia: NMBA-related perioperative anaphylaxis cases vs controls with uneventful anaesthesia
OR 4.2 (95% CI 2.3–7.0)
Observational data: associations, not effects.
Further findings
NMBA-related anaphylaxis and occupational exposure to quaternary ammonium compounds
| OR (95% CI) | ||
|---|---|---|
| Occupational exposure to quaternary ammonium compounds | 6.1 (2.7–13.6) | |
| 0.050.21520Odds ratio (log scale) |
Diagnostic value of pholcodine and quaternary ammonium specific IgE (sIgE) for NMBA-related reactions
- NPV
- 99.9%
- PPV
- <3%
Original publication
Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study. Br J Anaesth. Published 24 March 2023. doi:10. 1016/ j. bja. 2023. 02. 026
Composed by AI from the published abstract and checked against it. How Briefs are made →